doxazosin

Generic: doxazosin

Labeler: preferred pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name doxazosin
Generic Name doxazosin
Labeler preferred pharmaceuticals inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

doxazosin mesylate 4 mg/1

Manufacturer
Preferred Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 68788-8412
Product ID 68788-8412_06f89b42-45f3-4332-9f9e-8c23dae5fce6
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075580
Listing Expiration 2026-12-31
Marketing Start 2023-04-06

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 687888412
Hyphenated Format 68788-8412

Supplemental Identifiers

RxCUI
197627
UNII
86P6PQK0MU

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name doxazosin (source: ndc)
Generic Name doxazosin (source: ndc)
Application Number ANDA075580 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 4 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (68788-8412-1)
  • 30 TABLET in 1 BOTTLE (68788-8412-3)
  • 60 TABLET in 1 BOTTLE (68788-8412-6)
  • 90 TABLET in 1 BOTTLE (68788-8412-9)
source: ndc

Packages (4)

Ingredients (1)

doxazosin mesylate (4 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "06f89b42-45f3-4332-9f9e-8c23dae5fce6", "openfda": {"unii": ["86P6PQK0MU"], "rxcui": ["197627"], "spl_set_id": ["2110eec5-949d-4718-ad6d-3629e5db8a07"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (68788-8412-1)", "package_ndc": "68788-8412-1", "marketing_start_date": "20230406"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (68788-8412-3)", "package_ndc": "68788-8412-3", "marketing_start_date": "20230406"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (68788-8412-6)", "package_ndc": "68788-8412-6", "marketing_start_date": "20230406"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (68788-8412-9)", "package_ndc": "68788-8412-9", "marketing_start_date": "20230406"}], "brand_name": "Doxazosin", "product_id": "68788-8412_06f89b42-45f3-4332-9f9e-8c23dae5fce6", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "68788-8412", "generic_name": "Doxazosin", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxazosin", "active_ingredients": [{"name": "DOXAZOSIN MESYLATE", "strength": "4 mg/1"}], "application_number": "ANDA075580", "marketing_category": "ANDA", "marketing_start_date": "20230406", "listing_expiration_date": "20261231"}